Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study

P1.07-053 Apatinib for Chemotherapy-Refractory Extensive Stage SCLC: Results from a Single-Center Retrospective Study

(2017) Wei Hong et al.   Journal of Thoracic Oncology

Small Cell Lung Cancer

(2017) Gregory P. Kalemkerian et al.   Journal of the National Comprehensive Cancer Network

Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†

(2015) J.-L. Pujol et al.   ANNALS OF ONCOLOGY

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)

(2015) Neal E. Ready et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer

(2014) Neelesh Sharma et al.   INVESTIGATIONAL NEW DRUGS

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

(2013) Jin Li et al.   JOURNAL OF CLINICAL ONCOLOGY

Small-cell lung cancer

(2011) Jan P van Meerbeeck et al.   LANCET

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

(2010) Jin Li et al.   BMC CANCER

Treatment of extensive-stage small cell lung carcinoma: current status and future prospects

(2010) I. K. Demedts et al.   EUROPEAN RESPIRATORY JOURNAL

Maintenance or consolidation therapy in small-cell lung cancer: A systematic review and meta-analysis

(2010) Antonio Rossi et al.   LUNG CANCER